Navigation Links
Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
Date:7/7/2008

Expanded HCV Development Presence Includes ANA598 and ANA773 Acting via

Independent but Potentially Complementary Mechanisms

Conference Call Today at 2:00 PM PDT

SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it is resuming clinical investigation of the Toll-Like Receptor-7 (TLR7) mechanism for the treatment of chronic hepatitis C. Based on preclinical pharmacology testing and the results of completed 13-week GLP animal toxicology studies, Anadys has received clearance to initiate a clinical trial of ANA773, the Company's oral TLR7 agonist prodrug, under a clinical trial application (CTA) in the Netherlands. Following initial dosing in healthy volunteers, this trial will explore every-other-day dosing over 28 days in HCV patients. Anadys also continues to enroll patients in a separate Phase I clinical trial of ANA773 in oncology that is ongoing under an IND in the United States.

"In an extensive preclinical program conducted with ANA773, we have previously shown that the profile of immune stimulation resulting from TLR7 activation can be dramatically modulated by altering the schedule of administration," said James Freddo, M.D., Anadys' Chief Medical Officer. "Now, results of toxicology studies employing every-other-day dosing of ANA773 have shown that we can achieve desired levels of immune stimulation sustained over 13 weeks without adverse toxicology findings. The favorable toxicology profile seen to date, coupled with the stable induction of interferon-alpha dependent responses when ANA773 is dosed every other day over 13 weeks, have convinced us that ANA773 has the potential to demonstrate benefit in patients infected with HC
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
2. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
3. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
7. Isis Pharmaceuticals Conference Call Notice
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... , June 18, 2013  It has ... of Alliance Seating and Mobility, a subsidiary company ... access timely repair. This appears to be due ... reduction of field service employees.  ... great many of these clients are complex mobility ...
(Date:6/18/2013)... 2013  Recent regulatory and budget challenges have made ... at large pharmaceutical companies to effectively educate doctors and ... of their new products. With the pressure to reduce ... that these "Med Ed" groups find practical, ... address the changes that are transforming the Medical Education ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... Sept. 16 The American,Chemistry Council is aware ... today in,the Journal of the American Medical Association ... concentrations and medical,disorders in adults. As with any ... design of a study can limit interpretation of ...
... Biotech Begins to Demonstrate Strategy to Expand NHL ... Preclinical Development Program -, BRITISH COLUMBIA, Canada, ... OTC Bulletin Board: IXSBF;, http://www.ixsbio.com ), a drug ... based on its technology, Dynamic Cross,Linking (DXL(TM)), announced ...
Cached Medicine Technology:New Bisphenol A Study Has Limited Capability to Assess Human Health Effects 2InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies 2InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies 3
(Date:6/19/2013)... California (PRWEB) June 19, 2013 GoTunes ... iPhone, a free music and fitness app for creating ... can discover new Spotify songs that match your exercise ... they exercise, and add songs to your favorite playlists. ... songs curated by the GoTunes staff. , Get the ...
(Date:6/19/2013)... Weight gain and obesity have been ... including heart disease, kidney failure and high blood pressure. ... and unnecessary fat, have many people searching for fast ... diets to not only allow patients to succeed ... aim to reduce the risk for many weight-related health ...
(Date:6/19/2013)... After investing efforts for months in this ... announced the launch of database integration for the 2012 ... entry in the list of extraordinary vehicles lined up ... 2012 Nissan NV is all ready to get good ... Provided with two high power capable engines, the 2012 ...
(Date:6/19/2013)... Gainesville, FL (PRWEB) June 19, 2013 ... a new treatment solution for tinnitus patients, the ... medical term for noise or ringing in the ... of something serious within the body. , Using ... device creates a customizable and comforting sound stimulus ...
(Date:6/19/2013)... Miami, Florida (PRWEB) June 19, 2013 ... York Magazine, drug abusers called “psychonauts” are creating new ... based on their research of published documents and patented ... Here & Now on June 4. ... even physiologic effects. They’re never tested on humans. Maybe ...
Breaking Medicine News(10 mins):Health News:The GoTunes Iphone App Creates a Streaming Workout Music Community Via Spotify 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3
... ... imaging system for use in surveillance, defense, medical and machine vision applications. The embedded ... the potential to create a smart grid of imaging systems. , ... Rochester, NY (PRWEB) June 10, 2009 ...
... with rapid eye movement (REM) sleep refresh the brain,s ... negative bias and amplifying recognition of positive emotions, according ... Wednesday, June 10, at SLEEP 2009, the 23rd Annual ... show that the emotional brain is not stable across ...
... be Unveiled by SharpBrains CEO on June 11th, during Games for ... June 9 How can you take care of your brain ... which seem to contradict each other? Do supplements improve memory? Do ... of them enough? Which brain training approach, if any, is worth ...
... 2009In a joint effort by national laboratory-, university- and ... characterizing biological pathogens that could give rise to potentially ... first tool, an automated genotyping system, is a joint ... California at Los Angeles (UCLA) School of Public Health, ...
... could be key to a restful night, study finds , ... turning and having trouble getting a good night,s sleep, you ... primary insomnia reported that they slept better after trying meditation, ... at SLEEP, the annual meeting of the Associated Professional Sleep ...
... 9 Allied World Assurance,Company (U.S.) Inc., a member ... AWH ), today announced an added service to ... States. The,complimentary service, called "Strategic Response(SM)," provides policyholders,with 24/7 ... of a catastrophe. , Gordon ...
Cached Medicine News:Health News:FluxData, Inc. Introduces New Multispectral Camera with Embedded PC104 Computer 2Health News:FluxData, Inc. Introduces New Multispectral Camera with Embedded PC104 Computer 3Health News:Naps with rapid eye movement sleep increase receptiveness to positive emotion 2Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 2Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 3Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 4Health News:First Brain Training Consumer's Guide Debunks Ten Brain Health Myths and Reviews 21 Products 5Health News:Fast pandemic detection tool ready to fight flu 2Health News:Fast pandemic detection tool ready to fight flu 3Health News:Meditation May Help Put Primary Insomnia to Bed 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 3
Streck-Diluent CD is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1800....
... balanced electrolyte solution manufactured for use as ... sizing. Streck-Diluent III is for use on ... JS, JT, S-Plus IV, V, VI with ... 1400 and 1600. The shelf life is ...
Streck-Detergent III is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured for the Abbott CELL-DYN® 1400, 1600, 3500 and 3700. The shelf life...
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
Medicine Products: